Immunohistochemistry analysis showed that β-catenin expression was distributed in the membrane of cancer cells and significantly decreased in MALAT1-shRNA group compared with control group, and Ezh2 expression demonstrated the lower expression level in cell nucleus after MALAT1 knockdown (Figure 6E). The gene discussed is MALAT1; the disease is cancer.